Fighting Strokes at Lightspeed
Neurologists of the Kaiser Permanente Northern California Stroke FORCE team get clot-busting alteplase to patients twice as fast as the national average.
Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Division of Research’s Theodore Levin, MD, honored for colorectal cancer screening program
DOR's Theodore (TR) Levin, MD, is one of four recipients of The Permanente Medical Group's 2018 Sidney R. Garfield Exceptional Contribution Awards, for pioneering efforts to expand colorectal cancer screening.
Rare Cancer Carefully Tracked and Treated
Technology allows a panel of urologists and oncologists to provide the most up-to-date treatment for every single person with testicular cancer at Kaiser Permanente Northern California.
Integrated Program Improves Heart and Stroke Risk Factors in Those With Diabetes
Over a 10-year period, control of three key cardiovascular risk factors improved faster for Kaiser Permanente diabetes patients in Northern California than in the rest of the United States, according to research published in the American Journal of Medicine.
A Heart-to-Heart for Researchers
The second Cardiovascular Research Symposium drew approximately 80 people including researchers, sub-specialty physicians, quality and operational staff, and others from across Kaiser Permanente’s Northern California region. It was convened at the Division of Research (DOR) in Oakland by Alan S. Go, MD, DOR’s associate director of Cardiovascular and Metabolic Conditions Research.
Eight Weeks or Twelve? Kaiser Permanente Study Shows Shorter Hepatitis C Regimen Effective in Black Patients
A new study shows that a treatment regimen of 8 weeks for hepatitis C may be just as effective as 12 weeks in black patients. The study also showed that more people overall can take advantage of the shorter treatment durations, which has important implications for access given the medication’s high cost.
Historic Kaiser Permanente Artifact Donated to Smithsonian Institution
The Smithsonian recently received punch cards used in Kaiser Permanente’s multiphasic exam; the Division of Research (then the Medical Records Research) received its first U.S. Public Health Service grant to automate the results in 1962.
World’s Most Impactful Researchers List Includes Kaiser Permanente Northern California Scientist and Oncologist
Alan Go, MD, of the Kaiser Permanente Division of Research, and Kaiser Permanente Northern California oncologist Louis Fehrenbacher, MD, are among the less than 400 people named as Highly Cited Researchers in clinical medicine for 2017 by Clarivate Analytics. The annual list recognizes investigators whose research ranks in the top 1 percent most cited works in their field, indicating exceptional scientific impact.
Rapid research program seeks quick answers to pressing health care questions
An innovative program based at the Kaiser Permanente Division of Research is breaking down barriers between researchers and clinical leadership, allowing them to work together on short-term projects that can directly and quickly impact care.
Meet the Division of Research’s inaugural class of physician researchers
ROBERT CHANG, MD Vascular Surgery, South San Francisco “I’m thrilled to be a part of TPMG’s focus on clinical research with clearly defined goals to impact patient care. Our integrated health system, established IT infrastructure and supportive leadership will enable…
